Nextech Invest, Ltd.

CIK: 0001595430Latest portfolio: $1.0B · Q4 2025

Holdings

16

Total Value

$1.0B

New Positions

2

Closed Positions

1

Top Holdings

#StockSharesValue% PortfolioChangeType
1
RVMDREVOLUTION MEDICINES INC
7,601,087$605.4M58.53%
2
TYRATYRA BIOSCIENCES INC
4,055,861$106.6M10.31%
3
TNGXTANGO THERAPEUTICS INC
7,266,081$64.4M6.22%+1.7M
4
ORICORIC PHARMACEUTICALS INC
7,162,637$58.6M5.66%
5
RLAYRELAY THERAPEUTICS INC
4,701,506$39.8M3.85%+855K
6
ZYMEZYMEWORKS INC
1,113,946$29.3M2.84%
7
ALMSALUMIS INC
2,915,998$28.5M2.75%
8
KYMRKYMERA THERAPEUTICS INC
278,896$21.7M2.10%-62,013
9
ENGNENGENE HOLDINGS INC
2,124,943$19.2M1.85%NEW
10
MRSNMERSANA THERAPEUTICS INC
482,689$14.0M1.35%
11
CGEMCULLINAN THERAPEUTICS INC
1,141,145$11.8M1.14%
12
CNTXCONTEXT THERAPEUTICS INC
7,419,355$10.9M1.05%
13
SPRYARS PHARMACEUTICALS INC
660,703$7.7M0.74%
14
ARVNARVINAS INC
539,394$6.4M0.62%-869,000
15
SLNSILENCE THERAPEUTICS PLC
952,400$5.8M0.56%
16
GLUEMONTE ROSA THERAPEUTICS INC
279,237$4.4M0.42%NEW

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
TNGX7.3M+1.7M
RLAY4.7M+855K
ARVN539K+-869000

Decreased Positions

NameSharesChange
KYMR279K-62013

Sector Breakdown

Healthcare0.0% ($6.054261066286438e+63T)
Unknown0.0% ($14.0M)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 17, 2026$1.0B16
Q3 2025Nov 14, 2025$657.0B15
Q2 2025Aug 14, 2025$528.4B16
Q1 2025May 15, 2025$430.3B15

Fund Information

CIK0001595430
Most Recent FilingFeb 17, 2026
Number of Filings4

Nextech Invest, Ltd. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.0B across 16 holdings. The largest position is REVOLUTION MEDICINES INC (RVMD), representing 58.5% of the portfolio. Compared to the previous quarter, the fund opened 2 new positions and closed 1 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.